Literature DB >> 31961163

"It leaves me very skeptical" messaging in marketing prolonged exposure and cognitive processing therapy to veterans with PTSD.

Shannon M Kehle-Forbes1, Heather Gerould1, Melissa A Polusny1, Nina A Sayer1, Melissa R Partin2.   

Abstract

OBJECTIVE: Direct-to-consumer marketing has the potential to increase demand for specific treatments, but little is known about how to best market evidence-based psychotherapies to veterans with posttraumatic stress disorder (PTSD). The objective of this study was to gain an understanding of marketing messages that may impact veteran demand for prolonged exposure (PE) and cognitive processing therapy (CPT).
METHOD: Veterans (n = 31) with full or subthreshold PTSD participated in semistructured interviews that queried attitudes about PTSD and recovery, current knowledge of PE and CPT, and reactions to existing educational materials. A 2-stage qualitative coding and analytic strategy was used to identify primary themes related to the marketing of PE and CPT.
RESULTS: Veterans viewed the treatments' effectiveness as their primary selling point but questioned the credibility of improvement descriptions that didn't fit with their experiences or beliefs about PTSD. Participants had difficulties distinguishing CPT from non-trauma-focused approaches in which they had previously participated, leading to skepticism about promised treatment effects and decreased interest. Without targeting, women veterans assumed information regarding PTSD treatment options applied only to men.
CONCLUSIONS: Examination of the impact of a direct-to-consumer marketing campaign including these messages on PE and CPT demand is needed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 31961163      PMCID: PMC7369246          DOI: 10.1037/tra0000550

Source DB:  PubMed          Journal:  Psychol Trauma        ISSN: 1942-969X


  12 in total

1.  Factors associated with completing evidence-based psychotherapy for PTSD among veterans in a national healthcare system.

Authors:  Shira Maguen; Yongmei Li; Erin Madden; Karen H Seal; Thomas C Neylan; Olga V Patterson; Scott L DuVall; Callan Lujan; Brian Shiner
Journal:  Psychiatry Res       Date:  2019-02-11       Impact factor: 3.222

2.  Full and partial posttraumatic stress disorder: findings from a community survey.

Authors:  M B Stein; J R Walker; A L Hazen; D R Forde
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

3.  Acceptability of prolonged exposure therapy among U.S. Iraq war veterans with PTSD symptomology.

Authors:  Shannon M Kehle-Forbes; Melissa A Polusny; Christopher R Erbes; Heather Gerould
Journal:  J Trauma Stress       Date:  2014-08

Review 4.  A Review of Studies on the System-Wide Implementation of Evidence-Based Psychotherapies for Posttraumatic Stress Disorder in the Veterans Health Administration.

Authors:  C S Rosen; M M Matthieu; S Wiltsey Stirman; J M Cook; S Landes; N C Bernardy; K M Chard; J Crowley; A Eftekhari; E P Finley; J L Hamblen; J M Harik; S M Kehle-Forbes; L A Meis; P E Osei-Bonsu; A L Rodriguez; K J Ruggiero; J I Ruzek; B N Smith; L Trent; B V Watts
Journal:  Adm Policy Ment Health       Date:  2016-11

Review 5.  The development of a Clinician-Administered PTSD Scale.

Authors:  D D Blake; F W Weathers; L M Nagy; D G Kaloupek; F D Gusman; D S Charney; T M Keane
Journal:  J Trauma Stress       Date:  1995-01

6.  Direct-to-consumer marketing of psychological treatments: A randomized controlled trial.

Authors:  Kaitlin P Gallo; Jonathan S Comer; David H Barlow; Roberta N Clarke; Martin M Antony
Journal:  J Consult Clin Psychol       Date:  2015-06-22

7.  What people with PTSD symptoms do (and do not) know about PTSD: A national survey.

Authors:  Juliette M Harik; Rebecca A Matteo; Barbara A Hermann; Jessica L Hamblen
Journal:  Depress Anxiety       Date:  2016-10-27       Impact factor: 6.505

8.  "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.

Authors:  Jessica A Chen; Stephanie M Keller; Lori A Zoellner; Norah C Feeny
Journal:  J Nerv Ment Dis       Date:  2013-08       Impact factor: 2.254

9.  The effects of positive patient testimonials on PTSD treatment choice.

Authors:  Larry D Pruitt; Lori A Zoellner; Norah C Feeny; Daniel Caldwell; Robert Hanson
Journal:  Behav Res Ther       Date:  2012-10-05

10.  SYMPTOM BENCHMARKS OF IMPROVED QUALITY OF LIFE IN PTSD.

Authors:  Paula P Schnurr; Carole A Lunney
Journal:  Depress Anxiety       Date:  2016-02-16       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.